Evidence map›Paper›PMID 35624853›Full record

ReviewAntioxidants (Basel, Switzerland)2022

Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease.

Francesco Galli, Mario Bonomini, Desirée Bartolini, Linda Zatini, Gianpaolo Reboldi, Giada Marcantonini, Giorgio Gentile, Vittorio Sirolli, Natalia Di Pietro

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Effect ofLife (Basel, Switzerland) · 2025
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. The protective effects of the combination ofOpen veterinary journal · 2025
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Francesco GalliDepartment of Pharmaceutical Science, University of Perugia, 06126 Perugia, Italy.ORCID 0000-0003-3626-051X
Mario BonominiDepartment of Medicine and Aging, G. d'Annunzio University Chieti-Pescara, 66100 Chieti, Italy.
Desirée BartoliniDepartment of Pharmaceutical Science, University of Perugia, 06126 Perugia, Italy.
Linda ZatiniDepartment of Pharmaceutical Science, University of Perugia, 06126 Perugia, Italy.
Gianpaolo ReboldiDepartment of Medicine and Surgery, Centro di Ricerca Clinica e Traslazionale, CERICLET, University of Perugia, 06126 Perugia, Italy.
Giada MarcantoniniDepartment of Pharmaceutical Science, University of Perugia, 06126 Perugia, Italy.
Giorgio GentileRoyal Cornwall Hospitals, NHS Trust, Cornwall, Truro TR1 3LJ, UK.
Vittorio SirolliDepartment of Medicine and Aging, G. d'Annunzio University Chieti-Pescara, 66100 Chieti, Italy.
Natalia Di PietroDepartment of Medical, Oral and Biotechnological Sciences, Center for Advanced Studies and Technology-CAST, G. d'Annunzio University Chieti-Pescara, 66100 Chieti, Italy.ORCID 0000-0001-9720-2116
University of Perugia · ITUniversity of Chieti-Pescara · ITUniversity of Exeter · GB

Funding

Fondazione Cassa di Risparmio di Perugia 20420 - 2021.0339
6 · The paper itself

Abstract

Vitamin E (alpha-tocopherol) is an essential micronutrient and fat-soluble antioxidant with proposed role in protecting tissues from uncontrolled lipid peroxidation. This vitamin has also important protein function and gene modulation effects. The metabolism of vitamin E depends on hepatic binding proteins that selectively retain food alpha-tocopherol for incorporation into nascent VLDL and tissue distribution together with esterified cholesterol and triglycerides. Chronic kidney disease (CKD) is a condition of oxidative stress and increased lipid peroxidation, that are associated with alterations of alpha-tocopherol metabolism and function. Specific changes have been reported for the levels of its enzymatic metabolites, including both short-chain and long-chain metabolites, the latter being endowed with regulatory functions on enzymatic and gene expression processes important for the metabolism of lipids and xenobiotics detoxification, as well as for the control of immune and inflammatory processes. Vitamin E therapy has been investigated in CKD using both oral vitamin E protocols and vitamin E-coated hemodialyzers, showing promising results in the secondary prevention of cardiovascular disease, as well as of immune and hematological complications. These therapeutic approaches are reviewed in the present article, together with a narrative excursus on the main findings indicating CKD as a condition of relative deficiency and impaired metabolism of vitamin E.

Indexed as

antioxidantshemodialysislipid metabolismlipidomicsmembranesmetabolomicsrenal diseasetocopheroltocotrienolvitamin E

Identifiers

PMID35624853
PMCPMC9137556
OpenAlexW4280509196

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.